Liu Zhou, Julius Peter, Yalcin Dicle, Kang Guobin, Himwaze Cordilia Maria, Mucheleng'anga Luchenga Adam, Del Valle Luis, West John T, Wood Charles
Nebraska Center for Virology, School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Department of Interdisciplinary Oncology, Louisiana Cancer Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
J Infect Dis. 2025 Jul 30;232(1):90-100. doi: 10.1093/infdis/jiaf201.
Although antiretroviral therapy (ART) can suppress plasma viral loads in people living with human immunodeficiency virus (HIV), it cannot eliminate HIV-1 proviruses persisting in various tissue reservoirs, and HIV-1 will rebound after ART cessation. We have identified the appendix as a novel HIV tissue reservoir, but nothing is known about the provirus and the cellular tropism in this tissue.
We used single-genome analysis of HIV-1 env DNA and compared the viral sequences from appendix tissues and lymph nodes of the same people living with HIV-1. Sequential multiplex immunofluorescence labeling and RNAscope in situ hybridization on formalin-fixed, paraffin-embedded appendix sections were performed to identify cell types harboring HIV-1 proviral DNA in the appendix, by visualizing viral and cellular biomarkers colocalization.
The viral populations from the appendix were less heterogeneous than those from the lymph nodes in aviremic individuals, suggesting there is reduced ART selective pressure or the presence of appendix tropic HIV-1. Furthermore, we demonstrated that follicular dendritic cell (FDCs), rather than CD4+ T cells within the appendix, are the major cell type harboring subtype C HIV-1. Notably, although some subtype C HIV-1 signals could be remaining virions captured by FDCs even in aviremic individuals, HIV-1 proviral DNA was detected in some FDCs in the appendix tissues of aviremic individuals, indicating the presence of infected FDCs.
These results highlight the importance of analyzing all potential tissue and cellular tropism across different HIV-1 subtypes, to inform tailored therapeutic strategies for the diverse reservoirs that may differ across subtypes.
尽管抗逆转录病毒疗法(ART)可以抑制人类免疫缺陷病毒(HIV)感染者的血浆病毒载量,但它无法清除持续存在于各种组织储存库中的HIV-1前病毒,并且在ART停止后HIV-1会反弹。我们已将阑尾鉴定为一种新的HIV组织储存库,但对于该组织中的前病毒和细胞嗜性尚无了解。
我们对HIV-1 env DNA进行单基因组分析,并比较了来自同一HIV-1感染者的阑尾组织和淋巴结的病毒序列。通过可视化病毒和细胞生物标志物的共定位,对福尔马林固定、石蜡包埋的阑尾切片进行连续多重免疫荧光标记和RNAscope原位杂交,以鉴定阑尾中携带HIV-1前病毒DNA的细胞类型。
在病毒血症阴性个体中,阑尾来源的病毒群体比淋巴结来源的病毒群体异质性更低,这表明ART选择性压力降低或存在阑尾嗜性的HIV-1。此外,我们证明阑尾中的滤泡树突状细胞(FDC)而非CD4 + T细胞是携带C亚型HIV-1的主要细胞类型。值得注意的是,尽管即使在病毒血症阴性个体中,一些C亚型HIV-1信号可能是FDC捕获的残留病毒颗粒,但在病毒血症阴性个体的阑尾组织中的一些FDC中检测到了HIV-1前病毒DNA,这表明存在被感染的FDC。
这些结果凸显了分析不同HIV-1亚型的所有潜在组织和细胞嗜性的重要性,以便为不同亚型可能不同的多种储存库制定量身定制的治疗策略。